Description
CELLINK LAMININK 111 deliveres the reliable printability of CELLINK Bioink, enhanced with laminin 111 to support cell adhesion, migration, and differentiation. The bioink is suitable for 3D cultures of brain, kidney, liver, and intestinal cells and is relevant for Parkinson’s and cancer modeling. Formulated with our nanofibrillated cellulose, jointly patented with UPM‑Kymmene, CELLINK LAMININK 111 crosslinks easily with CaCl₂ Crosslinking Agent to create stable and supportive constructs.
Other specialized cell specific formulations available:
Specifications
| Appearance | White semi-translucent gel |
| Sterility | Sterile |
| pH |
6.5-7.4 |
| Viscosity | 2.0-5.3 kPa∙s at 0.01 s-1; 0,7-1.6 Pa∙s at 200 s-1 |
| Shelf life | Minimum 1,5 months |
| Storage conditions | 2-10°C, do not freeze |
| Kit components | CELLINK LAMININK 111 1×3 mL cartridge CaCl2 Crosslinking Agent, 45 mL |
| Use | For research use only. Not for human use. |
Publications
3D Bioprinting of Human Adipose-Derived Stem Cells and Their Tenogenic Differentiation in Clinical-Grade Medium
Stanco, D; Boffito, M; Bogni, A; Puricelli, L; Barrero, J; Soldati, G; Ciardelli, G. International Journal of Molecular Sciences, 21(22), 8694. (2020)
https://doi.org/10.3390/ijms21228694
